[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100613551":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":32,"collaborators":7,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":40,"acronym":41,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":7,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":61},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Giovanni Tallini, Prof.","CONTACT","+39 338 9763329","giovanni.tallini@ausl.bologna.it",[15],{"facility":16,"status":17,"city":18,"state":19,"zip":20,"country":21,"countryCode":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"IRCCS Azienda Ospedaliero Univesitaria di Bologna","RECRUITING","Bologna","BO","40138","Italy","IT",{"type":24,"coordinates":25},"Point",[26,27],11.33875,44.49381,{"lat":27,"lon":26},[30],{"name":10,"role":11,"phone":31,"phoneExt":7,"email":13},"+39 3389763329",{"type":33,"investigatorFullName":34,"investigatorTitle":35,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Giovanni Tallini","Prof.","100613551","implementation-of-the-methylome-in-the-characterization-of-solid-tumors-100613551",false,"NCT07268066","Implementation of the Methylome in the Characterization of Solid Tumors","AMethiST","Inclusion Criteria:\n\n* Confirmed diagnosis of one of the following types of cancer: gliomas, malignant thyroid neoplasms, or endometrial carcinomas (according to the WHO Nomenclature)\n* Availability of adequate material for analysis at the laboratory, specifically availability of at least 3 sections of 10 µm of FFPE\n\nExclusion Criteria:\n\n* no","ALL","18 Years",{"count":46,"type":47},180,"ESTIMATED","OBSERVATIONAL","This study aims to investigate the functional consequences of specific methylation changes and to examine the clinical implications of these alterations. Methylation analysis is a powerful tool for understanding the molecular mechanisms of brain tumors and other solid tumors and can help identify new diagnostic and therapeutic targets. By analyzing DNA methylation patterns in tumor tissue, it is possible to identify genes that are silenced or activated by methylation. This information can be used to develop new biomarkers for early diagnosis and to identify new therapeutic targets that can be used to reverse methylation-mediated gene silencing.",[51],"Solid Tumor Cancer","2025-12-10",{"date":54,"type":55},"2025-12-18","ACTUAL",{"date":57,"type":55},"2024-05-21",{"date":59,"type":47},"2026-12-31",{"name":5,"class":6},1]